美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）
检索条件:" 注册申请号=ANDA070967"
符合检索条件的记录共 4 条，共 1 页，当前第 1 页 ，可点击列名称排序
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
63323-461-57 63323-461 HUMAN PRESCRIPTION DRUG SENSORCAINE BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE INJECTION, SOLUTION INFILTRATION; PERINEURAL 20101119 N/A ANDA ANDA070967 Fresenius Kabi USA, LLC BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE 2.5 mg/mL; .005 mg/mL 25 VIAL, MULTI-DOSE in 1 TRAY (63323-461-57) / 50 mL in 1 VIAL, MULTI-DOSE (63323-461-01)
51662-1397-1 51662-1397 HUMAN PRESCRIPTION DRUG SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) INJECTION, SOLUTION INFILTRATION; PERINEURAL 20191008 N/A ANDA ANDA070967 HF Acquisition Co LLC, DBA HealthFirst BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE 2.5 mg/mL; .005 mg/mL 50 mL in 1 VIAL, MULTI-DOSE (51662-1397-1)
51662-1397-2 51662-1397 HUMAN PRESCRIPTION DRUG SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) INJECTION, SOLUTION INFILTRATION; PERINEURAL 20210126 N/A ANDA ANDA070967 HF Acquisition Co LLC, DBA HealthFirst BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE 2.5 mg/mL; .005 mg/mL 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1397-2) / 50 mL in 1 VIAL, MULTI-DOSE
51662-1397-3 51662-1397 HUMAN PRESCRIPTION DRUG SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE) INJECTION, SOLUTION INFILTRATION; PERINEURAL 20210126 N/A ANDA ANDA070967 HF Acquisition Co LLC, DBA HealthFirst BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE 2.5 mg/mL; .005 mg/mL 25 POUCH in 1 CASE (51662-1397-3) / 1 VIAL, MULTI-DOSE in 1 POUCH / 50 mL in 1 VIAL, MULTI-DOSE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase